VRTX:VIE
Vertex Pharmaceuticals Inc
€454.70
arrow_upward
+1.51%(+6.75) 1D
Oct 9, 5:36:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
€448.30
High
€454.70
Low
€448.30
Mkt. cap
129.29B
Avg. vol.
8.00
Volume
0.00
52-wk high
€481.60
52-wk low
€347.60
Shares outstanding
255.56M
No. of employees
6K
Open
€448.30
High
€454.70
Low
€448.30
Mkt. cap
129.29B
Avg. vol.
8.00
Volume
0.00
52-wk high
€481.60
52-wk low
€347.60
Shares outstanding
255.56M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
41 minutes ago
Vertex Pharma stock trades 0.88 percent below Xetra close of EUR 459.65 in weekend trading
Yahoo Finance Australia
·
12 hours ago
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
Investing.com
·
15 hours ago
Vertex reports pancreatic function recovery in young CF patients
Stock Titan
·
16 hours ago
Some young children with cystic fibrosis stopped pancreatic enzyme therapy in a study
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com